This was also validated in the TCGA cohort (p < 0.0001, Figure 1(c)), which indicated that higher ADAMTSL4 expression was enriched in GBM and may play a critical role in the malignant progression of glioma. The gene discussed is ADAMTSL4; the disease is central nervous system cancer.